Integra LifeSciences Holdings Corporation

NASDAQ:IART

Medical - Devices

Healthcare
$13.86 +4.71%

+$0.81 today

Market cap
$1.08B
Beta
1.25
P/E (TTM)
-2.8
EPS (TTM)
-$6.44
52W Low $8.70High $18.26

Volume 0.58M

Average 0.96M

IART Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

Integra LifeSciences Holdings CorporationNASDAQ: IART

Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other current liabilities rises 10.8% from a year ago

Other current liabilities stood at $58.04M at the end of Q1 FY2026, up 10.8% from a year earlier and down 21.7% from the prior quarter. Over 3 fiscal years it compounded at +4.2% a year.

Context

  • Other current liabilities amounted to 1.6% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
  • Other current liabilities increased in 2 of the last 3 fiscal years.

What to watch

Whether other current liabilities keeps rising in the next quarterly balance sheet after a +10.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$58.04M-21.7% QoQ
Last fiscal yearDec 2025
$74.08M+96.0% YoY
Year agoMar 2025
$52.38M+10.8% since
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+10.8%——
1 year+96.0%——
3-year CAGR+4.2%——
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
74.08M USD
Year-over-year change
+96.0%
4-year CAGR
-8.5%

Other Current Liabilities vs competitors

How IART compares with its peers on the latest reported figures

  • IART's Mar 2026 other current liabilities of $58.04M is the 5th highest of the 11 companies compared; the peer median is $35.56M.
  • Its year-over-year change of +10.8% is the 3rd highest of 9, against a peer median of -23.6%.
  • Other current liabilities amounts to 1.6% of total assets for IART, versus a peer median of 0.8%.
IART Competitors Peer median
Other Current Liabilities for IART and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SYKStryker CorporationJun 2026$2.6B -6.0%+5.3%5.4%
CNMDCONMED CorporationMar 2026$186.59M -0.1%+12.9%8.1%
OFIXOrthofix Medical Inc.Mar 2026$106.23M +13.1%—12.0%
SNNSmith & Nephew plcDec 2025$74M -41.3%-45.5%0.7%
IARTIntegra LifeSciences Holdings CorporationMar 2026$58.04M +10.8%+4.2%1.6%
AORTArtivion, Inc.Mar 2026$47.85M +268.0%+236.9%5.4%
GMEDGlobus Medical, Inc.Jun 2026$23.28M -86.7%+40.9%0.4%
XTNTXtant Medical Holdings, Inc.Mar 2026$407K ——0.5%
AXGNAxoGen, Inc.Sep 2026$0 -100.0%—0.0%
ATECAlphatec Holdings, Inc.Mar 2026$0 —+124.4%0.0%
TELATELA Bio, Inc.Jun 2026-$530K -107.5%+56.2%0.9%
Peer median (excluding IART) $35.56M-23.6%+40.9%0.8%

Competitors are the stored peer set for IART. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents513.45M456.66M276.4M246.38M235.05M
Short-term Investments0032.69M27.19M28.69M
Net Receivables243.24M263.47M259.33M272.37M278.85M
Inventory317.39M324.58M389.61M429.09M492.74M
Other Current Assets13.82M31.03M32.64M29.65M28.13M
Total Current Assets1.15B1.16B1.06B1.08B1.16B
Property, Plant & Equipment (Net)396.25M459.59M496.38M549.77M584.9M
Goodwill1.01B1.04B1.06B1.1B615.16M
Intangible Assets1.15B1.13B1.07B1.21B1.13B
Long-term Investments6.48M567.34M30.71M38.3M12.78M
Tax Assets56.95M45.99M46.08M34.92M69.85M
Other Non-current Assets9.96M(510.15M)27.48M28.21M25.1M
Total Non-current Assets2.63B2.73B2.72B2.96B2.44B
Total Assets3.78B3.89B3.78B4.04B3.6B
Account Payables61.84M102.1M92.33M82.5M95.73M
Short-term Debt59.78M52.75M14.53M607.08M126.55M
Tax Payables00003.65M
Deferred Revenue5.3M7.25M8.54M10.48M11.46M
Other Current Liabilities105.68M65.41M100.84M37.79M74.08M
Total Current Liabilities340.02M320.91M306.98M922.13M455.98M
Long-term Debt1.5B1.41B1.49B1.2B1.73B
Deferred Tax Liabilities45.79M63.34M35.32M60.83M5.66M
Deferred Revenue (Non-current)6.7M8.8M7.7M9.2M0
Other Non-current Liabilities120.26M138.5M192.24M137.04M204.28M
Total Non-current Liabilities1.76B1.76B1.89B1.57B2.1B
Total Liabilities2.1B2.09B2.19B2.49B2.56B
Common Stock896K905K909K916K923K
Retained Earnings698.57M879.12M946.86M939.92M423.44M
Accumulated OCI(45.16M)10.27M(15.11M)(27.57M)(30.08M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.68B1.8B1.59B1.55B1.04B
Total Debt1.67B1.63B1.68B1.98B2.03B
Net Debt1.15B1.17B1.41B1.74B1.8B

Integra LifeSciences Holdings Corporation

NASDAQ:IART

Intrinsic Alpha fair value

Locked

Current Price

$13.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.